Xience Skypoint
Device Vascular
PDI 08717648233678
General payments
$269,873
Research payments
$703,613
Through program year 2025, $269,873 in general payments and $703,613 in research payments were reported against Xience Skypoint (Vascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $65,216 | 65 |
| 2024 | General | $153,333 | 2,612 |
| 2024 | Research | $286,498 | 134 |
| 2023 | General | $116,540 | 2,338 |
| 2023 | Research | $351,899 | 148 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
4,950 general · 347 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.